CLINICAL TRIALS PROFILE FOR ISOSORBIDE DINITRATE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for Isosorbide Dinitrate
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Indication | NCT01478022 ↗ | To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 | Completed | Parent Project, Italy | Phase 1 | 2011-10-01 | This study will evaluate the pharmacokinetics plasma profile of 3 treatments: ISO 20, IBU 200 and IBU and ISO combinations (200 +20) given in single dose. This study is being conducted to support the submission for new indication in treatment of the combinations of Isosorbide Dinitrate and Ibuprofen as a treatment for Duchenne muscular dystrophy. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Isosorbide Dinitrate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000478 ↗ | Asymptomatic Cardiac Ischemia Pilot (ACIP) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1990-11-01 | To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia. |
| NCT00262470 ↗ | Treatment of Orthostatic Intolerance | Active, not recruiting | National Institutes of Health (NIH) | Phase 1/Phase 2 | 1997-04-01 | This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder. |
| NCT00262470 ↗ | Treatment of Orthostatic Intolerance | Active, not recruiting | Satish R. Raj | Phase 1/Phase 2 | 1997-04-01 | This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder. |
| NCT00337116 ↗ | Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients | Withdrawn | Soroka University Medical Center | Phase 4 | 2007-01-01 | This is a randomized, double blind, placebo-controlled study, clinical trail designed to evaluate the efficacy safety and superiority of intravenous boluses of isosorbide dinitrate for the relief of acute anginal pain episodes in acute coronary syndrome patients in comparison with the usual manner of S/L isosorbide dinitrate . |
| NCT00685945 ↗ | Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 | Completed | National Center for Research Resources (NCRR) | N/A | 2007-12-01 | The purpose of the study is to determine if giving isosorbide,a drug that is used to treat chest pain, affects blood vessel release of an anti-clotting factor. |
| NCT00685945 ↗ | Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | N/A | 2007-12-01 | The purpose of the study is to determine if giving isosorbide,a drug that is used to treat chest pain, affects blood vessel release of an anti-clotting factor. |
| NCT00685945 ↗ | Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 | Completed | National Institutes of Health (NIH) | N/A | 2007-12-01 | The purpose of the study is to determine if giving isosorbide,a drug that is used to treat chest pain, affects blood vessel release of an anti-clotting factor. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Isosorbide Dinitrate
Condition Name
Clinical Trial Locations for Isosorbide Dinitrate
Trials by Country
Clinical Trial Progress for Isosorbide Dinitrate
Clinical Trial Phase
Clinical Trial Sponsors for Isosorbide Dinitrate
Sponsor Name
